Intellipharmaceutics Corp.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Intellipharmaceutics Corp..The latest application filed is for "compositions and methods for reducing overdose".

Company Profile

9.19.7

Intellipharmaceutics Corp. - Ontario CA
Intellipharmaceutics Corp. - Toronto CA
INTELLIPHARMACEUTICS CORP - Toronto CA
Intellipharmaceutics Corp. - Mississauga, Ontario N/A CA
Intellipharmaceutics Corp. - Mississauga CA
INTELLIPHARMACEUTICS CORPORATION - Toronto Ontario CA
Intellipharmaceutics Corp - Mississauga CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Abuse and alcohol resistant drug composition Grant 10,960,077 - Odidi , et al. March 30, 2	2021-03-30
Compositions and methods for reducing overdose Grant 10,653,776 - Odidi	2020-05-19
Pharmaceutical composition having reduced abuse potential Grant 10,632,205 - Odidi , et al.	2020-04-28
Controlled release composition using transition coating, and method of preparing same Grant 10,624,858 - Odidi , et al.	2020-04-21
Compositions And Methods For Reducing Overdose App 20190275153 - Odidi; Isa	2019-09-12
Controlled release delivery device comprising an organosol coat Grant 10,314,787 - Odidi , et al.	2019-06-11
Compositions and methods for reducing overdose Grant 10,293,046 - Odidi	2019-05-21
Controlled Release Delivery Device Comprising An Organosol Coat App 20190076363 - ODIDI; Isa ; et al.	2019-03-14
Controlled release delivery device comprising an organosol coat Grant 10,159,649 - Odidi , et al. Dec	2018-12-25
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems App 20180333362 - ODIDI; ISA ; et al.	2018-11-22
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems Grant 10,064,828 - Odidi , et al. September 4, 2	2018-09-04
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient Grant 9,636,306 - Odidi , et al. May 2, 2	2017-05-02
Controlled Release Delivery Device Comprising An Organosol Coat App 20170112770 - ODIDI; Isa ; et al.	2017-04-27
Controlled release delivery device comprising an organosol coat Grant 9,561,188 - Odidi , et al. February 7, 2	2017-02-07
Proton Pump-inhibitor-containing Capsules Which Comprise Subunits Differently Structured For A Delayed Release Of The Active Ingredient App 20140322312 - Odidi; Isa ; et al.	2014-10-30
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient Grant 8,802,139 - Odidi , et al. August 12, 2	2014-08-12
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors Grant 8,603,520 - Odidi , et al. December 10, 2	2013-12-10
Controlled Release Drug Delivery Compostion App 20130095176 - ODIDI; Isa ; et al.	2013-04-18
Controlled extended drug release technology Grant 8,394,409 - Odidi , et al. March 12, 2	2013-03-12
Syntactic deformable foam compositions and methods for making Grant 6,800,668 - Odidi , et al. October 5, 2	2004-10-05
Extended release metformin hydrochloride formulations Grant 6,676,966 - Odidi , et al. January 13, 2	2004-01-13
Controlled release formulation containing bupropion Grant 6,652,882 - Odidi , et al. November 25, 2	2003-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.